The gift, from Andrew and Kate Davis and the Shelby Cullom Davis Charitable Fund, will be used to advance research working to predict and ultimately prevent Alzheimer’s disease.
“Our talented team of Alzheimer’s researchers have dedicated their lives to finding ways to disrupt this disease,” said Betsy Nabel, MD, Brigham and Women’s Hospital president. “We are exceedingly grateful to the Davis family for their transformative gift that will significantly accelerate our work and bring us closer to our ultimate goal of eradicating Alzheimer’s.”
The new program will be named the Davis Alzheimer Prevention Program to honor the donors.
More articles on healthcare finance:
20 healthcare companies that gave back their PPP loans
Elective surgery pause in Texas is bad credit news for hospital operators
HealthPartners to lay off 200, close clinics
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
